HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

AMED Faces Face-to-Face Rule

Share
By: Zacks Equity Research
March 17, 2011 | Comment(s): 0
Recommended this article (6)
AMED | GTIV | NHC

Amedisys (AMED - Snapshot Report), one of the leading US players in the home health and hospice segment has planned to participate in an online seminar to settle the commotion that has been created due to the Face-to-Face rule. This rule, imposed by the Centers for Medicare & Medicaid Services (CMS), has created confusion regarding Amedisys’ role.

Amedisys will be accompanied by two other national home health care providers in the webinar titled, ‘Making Sense of the New Medicare Face-to-Face Requirements for Home Health Care and Hospice’, to be held on March 23, 2011.

This seminar will be an interactive one, dealing with details on the needs imposed on physicians and the home health and hospice people in the patient protecting Face-to-Face encounter rules. This regulation on how home health agencies will be able to fulfill face-to-face encounter requirements for patients, has been effective from January 2011.

Amedisys provides care to more than 35 thousand US patients each day. Apart from hospice services to patients, the company carries out programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, and complex wound care. Amedisys expects strong growth in the near future as the demand for alternative to hospitals has been rising as it helps to do away with costly hospitalization.

However, presently Amedisys is going through a difficult phase primarily due to the investigation on the company and some of its competitors by the Senate Finance Committee, the Securities and Exchange Commission (SEC) and some other agencies for abuse of Medicare rules. The investigations are being conducted to check if these companies had deliberately increased the number of patient visits to receive higher Medicare reimbursements.

Moreover, Amedisys faces stiff competition from the home health agencies and bigger companies like National HealthCare Corporation (NHC - Snapshot Report) and Gentiva Health Services (GTIV - Analyst Report), which makes the building of its foothold a more challenging task. Also there are increasing concerns regarding Medicare reimbursements especially following the release of President Obama's budget proposal, which included over $37 billion of home health savings (over 10 years).

Read the full analyst report on AMED

Read the full analyst report on GTIV

Read the full analyst report on NHC

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 11:08 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center